Preview

Abbott Piramal Deal

Satisfactory Essays
Open Document
Open Document
522 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Abbott Piramal Deal
Abbott-Piramal Healthcare – Deal analysis

Deal overview
► On 21 May 2010, Abbott Laboratories announced the acquisition of the healthcare solutions business (domestic formulations business) of India based Piramal Healthcare for an up-front payment of US$2.12 billion. In addition to this, Abbott will also pay US$400 million annually for the next four years, beginning in 2011 .
► Abbott is a global health care company engaged in the discovery, development, manufacture and marketing of pharmaceuticals and medical products.
► Mumbai-based Piramal Healthcare Solutions is a leading provider of Indian branded generics, with a portfolio of around 350 products, including therapeutic areas such as antibiotics, respiratory diseases, diabetes and cardiovascular diseases.

Deal highlights
► According to the terms of the agreement, Abbott will obtain access to Piramal's manufacturing facilities in Baddi in Himachal Pradesh as well as the rights to sell more than 350 brands in the domestic market .
► Around 5,000 employees of Piramal's Healthcare Solutions will now become part of Abbott, which will take Abbott’s headcount to 7,500 in India2.
► Piramal Healthcare will retain its Custom Manufacturing business, its Critical Care business, over-the-counter (OTC) Consumer Products business, bulk-drug manufacturing business and Diagnostics business2.
► Piramal will not engage in generic pharmaceutical business in India and other emerging markets for the next eight years2.

Implications of the deal
► Abbott could become the leading pharmaceutical company in India: Piramal’s Healthcare Solutions division is expected to generate more than US$500 million in revenues in 2011 and continue to grow at 20%, with sales reaching US$2.5 billion by 2020. With this deal, Healthcare Solutions and Abbott’s businesses will cumulatively become the market leader in India, with

You May Also Find These Documents Helpful

  • Powerful Essays

    Teva Pharmacuetical

    • 2882 Words
    • 12 Pages

    More than 100 years ago Teva Pharmaceuticals opened their doors as a wholesale drug distributor in Jerusalem. Today they have become the world’s leading producer of generic pharmaceuticals. Revenue has grown from $91 million in 1985 to $8.5 billion in 2006. This growth has not been easy and derives from key strategic decisions made along the way in order to amass these huge dollars amounts. Teva’s mission is to play a leading role in the transformation of the healthcare system through the development, manufacture and marketing of generic pharmaceuticals. Teva’s organizational structure is a symbol of their fundamental business strategy, highlighting their global strength and pharmaceutical diversity. This allows them to continue to expand their core generic business across all geographies and leverage their global reach and scientific strength to develop new innovative products and technologies. Teva has picked an industry in which there will always be a need, medicine. However, it is their approach to prescription medicine that will decide the future of Teva.…

    • 2882 Words
    • 12 Pages
    Powerful Essays
  • Powerful Essays

    cardinal health inc

    • 1287 Words
    • 4 Pages

    The case introduces us to the Cardinal Inc which for now is the leading manufacturer in the products of medical it has its own pharmaceuticals. Company is one of the fortune 500 companies the head office is in Dublin, Ohio. So, talking about pharmaceuticals and medical products its wide services offers to more than one hundred thousand locations. it does has its own products of medical and surgical it almost includes all the types of the surgical apparel and other equipment. so, what we can conclude is it is the largest medical company it has a wide coverage of almost 75% of hospitals in U.S.it has not only given services alone it has also some of the tie ups with other companies, so they are proven to be the best ,biggest and cheapest medical suppliers in U.S. So, beginning of their starting was a long back nearly 45 years long history is what they carried with them with the name of their own in the pharmaceuticals company. it actually serves as the middle person as it connects the providers and manufactures, we can view them as a broker too. The employees are more than 30000 all around the world but during their starting they have developed themselves as the cardinal Foods inc which they later diversified in to the medical products. The long term vision of Cardinal is to be the top leader in the name of medical and Pharmaceuticals Company through continuous development, innovation, research and development, scanning environment whereas the mission of them are to retain, collect and to identify the biggest opportunities in the market place. They want to be best by serving through the best to the customers they will to win the heart of the customers through their excellent service.…

    • 1287 Words
    • 4 Pages
    Powerful Essays
  • Powerful Essays

    $9.8 billion over six years in once-in-a-generation school reforms to enhance Australia's future productivity and wellbeing, ensuring that every student in every school gets the help they need.…

    • 1257 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    Business

    • 330 Words
    • 2 Pages

    4. Does Pfizer need to change the structure of its organization? If so, what changes are…

    • 330 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    | This firm is the world’s largest prescription-pharmaceutical company, and has a very broad and deep pipeline of ethical pharmaceutical, supported by robust research and development budget. The company has divested several of its non-pharmaceutical businesses, and become the partner of choice for licensing deals with other pharmaceutical and biotechnology firms…

    • 2519 Words
    • 11 Pages
    Powerful Essays
  • Powerful Essays

    The health care industry Provides health products and service which involved the leading technology of life science. It is a fast-growing industry and will continue to grow in the future because of the increasing request to the advanced medical care. The Global Industry Analysis (GIA,2009) predicted that the prescription drug market is value around $897 billion in world economy in 2015, and Asia-Pacific region is expected to have highest growth in prescription drugs.…

    • 1121 Words
    • 5 Pages
    Powerful Essays
  • Best Essays

    Pfizer Industry Review

    • 4325 Words
    • 18 Pages

    Since the 1950s, the global pharmaceutical industry has evolved from “…a collection of several hundred, small, barely profitable firms to as small group of large, highly profitable firms” (Younkin, 2008, para. 1). This evolution has resulted in an oligopoly market structure with a few large firms, and significant barriers to market entry. In the last 20 years, pharmaceutical consolidation has continued with both vertical and horizontal mergers that have further shrunk the market. Since 1995, Pfizer has merged with five pharmaceutical firms (Industry Brief, 2003) in an attempt to increase its research and development divisions and to offset declines in new product development; increases in generic competition; and the emergence of bio-pharmaceutical firms (BCC Research, 2004). Although pharmaceutical firms no longer view mega mergers as “…a cure-all for [their] innovation drought” (Simons, 2007, para. 1), this trend towards consolidation is expected to continue, with firms focusing “…on targeted acquisitions and alliances with smaller…more innovative drug makers and biotechs” (Simons, 2007, para. 10).…

    • 4325 Words
    • 18 Pages
    Best Essays
  • Powerful Essays

    Merck vs Pfizer

    • 7395 Words
    • 30 Pages

    References: Allasraki, M. (2011, February 27). The 10 biggest-selling drugs that are about to lose their patent. Retrieved from http: http://www.dailyfinance.com/2011/02/27/top-selling-drugs-are-about-to-lose-patent-protection-ready/…

    • 7395 Words
    • 30 Pages
    Powerful Essays
  • Good Essays

    Recovering Sales Growth: The company’s sales have taken a major hit over the past 5 years, going from nearly $150,000 million in 2007, to an estimated $125,000 million in 2012, however the sales slide has seemed to bottom and is projected to reach 2007 levels by 2016…

    • 782 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    The sales of the product are set to increase 17-fold from to 2013 to 2028.…

    • 320 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Global Xanthan Gum

    • 208 Words
    • 1 Page

    to reach as much as USD 1.25 billion by the end of 2024, after being calculated at USD…

    • 208 Words
    • 1 Page
    Satisfactory Essays
  • Good Essays

    Genentech Case Study

    • 564 Words
    • 3 Pages

    Start searching for economical and strategic locations for building up of new manufacturing plant. It’s important to keep looking for space and be ready with a blue print of an additional facility.…

    • 564 Words
    • 3 Pages
    Good Essays
  • Good Essays

    2011 they have shown revenue growth year after year. In 2002 they showed sales revenues of $9.2 billion,…

    • 2493 Words
    • 10 Pages
    Good Essays
  • Powerful Essays

    The giants of the drug industry are looking for companies that have assets (potential drugs) that may fill the gap when patent protection is lost to generics. For Bristol-Meyers one of the more recent examples of this occurred as early as May of this year when its top seller Plavix a blood thinner faced generic competition for the first time. In 2011 Plavix was a $7.1 billion dollar boon to Bristol-Meyers. That is…

    • 3058 Words
    • 13 Pages
    Powerful Essays
  • Good Essays

    Gaspier Jeans

    • 2578 Words
    • 21 Pages

    million in five years, which speaks volumes about the potential of the company and the industry.…

    • 2578 Words
    • 21 Pages
    Good Essays